TOMPKINS MARK N. purchased 1.7% of their position (25K shares) of TRANSPHORM, INC. on the open market
Open‑market purchase worth $100.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/14/2020ACC: 0001213900-20-004044
Director10% Owner
Since Oct 2017
-632.70K
Net shares
Net seller
$100.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
25K acquired · 657.70K disposed
Non-Derivative Transactions2
Common Stock, par value $0.0001
Direct
Shares
−657.70K
Price / share
—
Trade value
—
% of position
30.5%
2/12/2020
2.16M→1.50M
Common Stock, par value $0.0001
Direct
Shares
+25K
Price / share
$4.00
Trade value
$100K
% of position
1.7%
2/12/2020
1.50M→1.52M
Total
Net shares
−632.70K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 Direct | 2/12/2020 | J · J | −657.70K | — | — | 30.5% | 2.16M | 1.50M |
| Common Stock, par value $0.0001 Direct | 2/12/2020 | P · Purchase | +25K | $4.00 | $100K | 1.7% | 1.50M | 1.52M |
| Total | −632.70K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported